Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin.
Dominik BiegDaniel SypniewskiEwa NowakIlona Anna BednarekPublished in: Archives of gynecology and obstetrics (2018)
Morin sensitizes TOV-21G and SK-OV-3 ovarian cancer cells to cisplatin, what is associated with a decrease of the expression of galectin-3.